期刊文献+

EZH2基因在肾透明细胞癌中的表达及其意义 被引量:4

Expression of EZH2 in clear cell carcinoma and its significance
下载PDF
导出
摘要 目的探讨EZH2(enhancer of zeste homolog 2,EZH2)基因在肾透明细胞癌中的表达及其临床意义。方法采用免疫组织化学法分别检测正常肾脏组织(8例)及肾透明细胞癌标本(58例)中EZH2蛋白的表达。结果正常肾脏组织与肾透明细胞癌标本EZH2蛋白表达率分别为12.5%(1/8)、74.1%(43/58)(P<0.05)。肾透明细胞癌标本中,局部进展性肾癌(Ⅲ)与转移性肾癌(Ⅳ)EZH2蛋白表达明显高于局限性肾癌(Ⅰ+Ⅱ)(P<0.05);高分化肾癌、中分化肾癌及低分化肾癌EZH2蛋白表达不具有显著性差异。结论EZH2在肾透明细胞癌明显高表达,提示其与肾透明细胞癌的发生、发展密切相关,对于肾透明细胞癌的早期诊断及判断预后可能有重要的意义。 Objective To explore the expression of EZH2 in clear cell carcinoma and its significance. Methods EZH2 protein expression was assessed by immunohistochemical method in tissue specimens of normal nephridium and clear cell carcinoma. Results The rate of EZH2 protein expression was 12.5% and 74.1% (P〈0. 05) in the normal nephridium group and the clear cell carcinoma group, respectively. EZH2 protein expression was increased in localized advanced renal cell carcinoma ( Ⅲ ) and metastatic renal cell carcinoma ( Ⅳ ) compared with localized renal cell carcinoma (Ⅰ + Ⅱ ) (P 〈 0. 05). There were no significant differences in EZH2 protein expression levels among well-differentiated renal cell carcinoma, moderately differentiated renal cell carcinoma and poorly differentiated renal cell carcinoma. Gonclusion Our data show a significant increase in EZH2 expression in clear cell carcinoma compared with normal nephridial tissue, which suggests that increased EZH2 overexpression correlates with oncogenesis and development of clear cell carcinoma. EZH2 may play an important role in early diagnosis and prognosis for clear cell carcinoma.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第2期218-220,共3页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 肾透明细胞癌 EZH2 基因表达 免疫组化 clear cell carcinoma EZH2 gene expression immunohistochemistry
  • 相关文献

参考文献13

  • 1BRACKEN AP, PASINI D, CAPRA M, et a1. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer [J]. EMBO, 2003, 22(20):5323-5335.
  • 2TAKAHASHI M, YANG XJ, LAVERY TT, et al. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features [J]. Cancer Res, 2002, 62(22):6598-6605.
  • 3MIMORI K, OGAWA K, OKAMOTO M, et al. Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases [J]. Eur J Surg Oncol, 2005, 31(4):376-380.
  • 4CHEN H, TU SW, HSIEH JT. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer [J]. Biol Chem, 2005, 280(23):22437-22444.
  • 5RAAPHORST FM, MEIJER CJ, FIERET E, et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene [J]. Neoplasia, 2003, 5(6):481-488.
  • 6SU IH, BASAVARAJ A, KRUTCHINSKY AN, et al. EZH2 controls B cell development through histone H3 methylation and Igh rearrangement [J]. Nat Immunol, 2003, 4(2):101-103.
  • 7VIR E, BRENNER C, DEPLUS R, et al. The Polycomb group protein EZH2 directly controls DNA methylation [J]. Nature, 2006, 439(7078):871-874.
  • 8KUZMICHEV A, JENUWEIN T, TEMPST P, et al. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3 [J]. Mol Cell, 2004, 14(2):183-193.
  • 9TONINI T, BAGELLA L, DANDRILLI G, et al. EZH2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A [J]. Oncogene, 2004, 23(28):4930-4937.
  • 10ARISAN S, BUYUKTUNCER ED, PALAVAN-UNSAL N, et al. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma [J]. Urol Int, 2005, 75(3):252-257.

同被引文献84

  • 1张嘉玲,苏秀兰,闫美荣,呼群.shRNA沉默EZH2表达对人肺癌细胞增殖和侵袭能力的影响[J].中华临床医师杂志(电子版),2011,5(20):5871-5874. 被引量:7
  • 2胡沙,王静,李智敏,郭剑锋,于利利,杨纯,王泽华.EZH2基因在人卵巢癌顺铂耐药株中的表达及其对细胞耐药性的影响[J].肿瘤,2010,30(9):748-752. 被引量:9
  • 3龚志斌,厉有名,虞朝辉.EZH2在肝细胞性肝癌中的表达及其对HepG2增殖作用的研究[J].实用肿瘤杂志,2006,21(6):523-526. 被引量:6
  • 4刘桂芝,吴逸明,杨继要.非小细胞肺癌组织中RASSF_(1A)和p16基因启动子甲基化研究[J].陕西医学杂志,2007,36(5):515-520. 被引量:5
  • 5Ringrose L,Paro R.Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins[J].Annu Rev Genet,2004,38(11):413-443.
  • 6Jacobs JJ,Kieboom K,Marino S,et al.The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus[J].Nature,1999,397(6715):164-168.
  • 7Weikert S,Christoph F,Kollermann J,et al.Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas[J].Int J Mol Med,2005,16(2):349-353.
  • 8Jacobs JJ,Scheijen B,Voncken JW,et al.Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF[J].Genes Dev,1999,13(20):2678-2690.
  • 9Masunaga R,Kohno H,Dhar DK,et al.Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients[J].Clin Cancer Res,2000,6(10):4064-4068.
  • 10Song LB,Zeng MS,Liao WT,et al.Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells[J].Cancer Res,2006,66(12):6225-6232.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部